MMNFQ (MedMen Enterprises) Net Margin %: -115.65% (As of Mar. 2023)


What is MedMen Enterprises Net Margin %?

MedMen Enterprises MMNFQ -90.00% Net Margin % is -115.65% as of Mar. 2023.

Net margin is calculated as Net Income divided by its Revenue. MedMen Enterprises's Net Income for the three months ended in Mar. 2023 was $-31.5 Mil. MedMen Enterprises's Revenue for the three months ended in Mar. 2023 was $27.2 Mil. Therefore, MedMen Enterprises's net margin for the quarter that ended in Mar. 2023 was -115.65%.

The historical rank and industry rank for MedMen Enterprises's Net Margin % or its related term are showing as below:


MMNFQ's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.56
* Ranked among companies with meaningful Net Margin % only.

MedMen Enterprises  (OTCPK:MMNFQ) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

MedMen Enterprises Net Margin % Related Terms

MedMen Enterprises Net Margin % Historical Data

* Premium members only.

The historical data trend for MedMen Enterprises's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedMen Enterprises Net Margin % Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -169.96 -57.61 -159.23 -93.87 -138.62

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -84.39 -273.45 13.85 -54.84 -115.65

MMNFQ vs ZTS, VTRS, NBIX: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedMen Enterprises Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's Net Margin % distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's Net Margin % falls into.


MedMen Enterprises Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

MedMen Enterprises's Net Margin for the fiscal year that ended in Jun. 2022 is calculated as

Net Margin=Net Income (A: Jun. 2022 )/Revenue (A: Jun. 2022 )
=-195.187/140.812
=-138.62 %

MedMen Enterprises's Net Margin for the quarter that ended in Mar. 2023 is calculated as

Net Margin=Net Income (Q: Mar. 2023 )/Revenue (Q: Mar. 2023 )
=-31.487/27.225
=-115.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -115.65% mean?
MedMen Enterprises (MMNFQ) has a Net Margin % of -115.65% as of Mar. 2023. Net margin is the ratio of total net income to net sales. View historical data on MedMen Enterprises and its competitors.
Is MedMen Enterprises' Net Margin % too high?
MedMen Enterprises' current Net Margin % is -115.65%.
How does MedMen Enterprises' Net Margin % compare to ZTS and VTRS?
MedMen Enterprises' Net Margin % of -115.65% can be compared against companies in the Drug Manufacturers industry. The industry median Net Margin % is 5.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on MedMen Enterprises and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedMen Enterprises's current Net Margin % is -115.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedMen Enterprises stock overvalued right now?
MedMen Enterprises (MMNFQ) has a current Net Margin % of -115.65%. The current Net Margin % is -115.65%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For MedMen Enterprises (MMNFQ), the current Net Margin % is -115.65% as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedMen Enterprises Business Description

Address 8740 S Sepulveda Boulevard, Suite 105, Los Angeles, CA, USA, 90045
MedMen Enterprises Inc is a American cannabis company dedicated to improving life with Cannabis for All. With operations across the United States in California, Nevada, Illinois, Arizona, Massachusetts, and New York, the company has MedMen and LuxLyte brands offering cannabis in consumer-preferred product forms for medical and recreational use. It produces and curates the consumer product assortment for retail operations in its local communities, and drives consumer loyalty with service and engaging in-store experience, combined with reward, delivery, and e-commerce programs.